EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Use of integrated spatial transcriptomics and histopathological analysis in adamantinomatous craniopharyngiomas to identify stromal cells as a new cellular source of leukemia inhibitory factor

Wenxin Hu, Chuan Zhao, Wenrong Zheng, Yi Lin, Ning Luo, Hongxing Liu, Xingfu Wang, Xueling Qi, Xianlong Wang, Xiao-Nan Li, Zhixiong Lin

Journal of Neurosurgery · 2025

DOI: 10.3171/2025.4.jns243146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosurgery, 2025. Verfasst von Wenxin Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery, Sanbo Brain Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Leukemia Inhibitory Factor, Craniopharyngioma, Stromal Cells, Pituitary Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Adamantinomatous craniopharyngioma (ACP) is an epithelial tumor that occurs in the sellar region of the human brain. Despite resection, relapse is frequent with poor prognosis. To facilitate the development of new therapy for ACP, the authors examined the spatial distribution, cell of origin, and potential biological functions of leukemia inhibitory factor (LIF), an important stem cell self-renewal regulator, in a series of ACP tumors. METHODS The transcriptional sites of LIF and LIF receptor (LIFR) were determined by single-cell sequencing and space transcriptome analysis. LIF and LIFR distribution characteristics in different histopathological regions were detected with immunohistochemistry and immunofluorescence analysis. The relationships between the regional distributions of different tissues and tumor imaging characteristics, tumor cell stemness, cell proliferation, LIF expression, and patient prognosis were analyzed. RESULTS The authors’ analysis of 39 ACPs detected LIF overexpression that was selectively enriched in cell clusters. In addition to the discovery of the stromal cells in the interstitial region, palisade epithelium, and stellate reticulum as the source cells of LIF production, the authors also revealed that LIFR was primarily generated by the cell clusters. Examination of differentially expressed genes between LIF-high and LIF-low ACP tumors indicated that the binding of LIF to LIFR may lead to the activation of the PI3K-AKT signaling pathway. Further analysis showed enrichment of LIF expression in β-catenin–positive cell clusters expressing stem cell markers of CD44, supporting its role in stem cell self-renewal. Integrated analysis with diagnostic imaging found higher level expression of LIF in cystic tumors than in solid tumors, displaying a trend toward poorer prognosis. CONCLUSIONS This study confirmed for the first time that LIF in ACP mainly originates from tumor microenvironment stroma. The authors’ data suggest that future efforts should also include tumor stromal cells as a novel cellular and/or molecular target when developing new anticancer therapies against ACP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia Inhibitory FactorCraniopharyngiomaStromal CellsPituitary NeoplasmsTranscriptomeHumansFemaleMaleAdultAdolescentChildGene Expression ProfilingMiddle AgedLeukemia Inhibitory Factor Receptor alpha SubunitYoung AdultSingle-Cell Analysis

Stichwörter der Autor:innen

adamantinomatous craniopharyngiomacell clusterleukemia inhibitory factorproliferationstem celltumor

Substanzen

Leukemia Inhibitory FactorLIF protein, humanLIFR protein, humanLeukemia Inhibitory Factor Receptor alpha Subunit

Autor:innen und Institutionen

  • 1Department of Neurosurgery, Sanbo Brain Hospital of Capital Medical University, Beijing, China.
  • 2Department of Neuro-Oncology, Sanbo Brain Hospital of Capital Medical University, Beijing, China.
  • 3Department of Neurosurgery, Beijing Ditan Hospital of Capital Medical University, Beijing, China.
  • 4Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
  • 5Department of Pathology, Sanbo Brain Hospital of Capital Medical University, Beijing, China.
  • 6Department of Bioinformatics, School of Medical Technology and Engineering, Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, Fujian, China.

Zitieren

APA

Hu, W., Zhao, C., Zheng, W., Lin, Y., Luo, N., Liu, H., Wang, X., Qi, X., Wang, X., Li, X. N., & Lin, Z. (2025). Use of integrated spatial transcriptomics and histopathological analysis in adamantinomatous craniopharyngiomas to identify stromal cells as a new cellular source of leukemia inhibitory factor. Journal of Neurosurgery. https://doi.org/10.3171/2025.4.jns243146

Vancouver

Hu W, Zhao C, Zheng W, Lin Y, Luo N, Liu H, et al. Use of integrated spatial transcriptomics and histopathological analysis in adamantinomatous craniopharyngiomas to identify stromal cells as a new cellular source of leukemia inhibitory factor. Journal of Neurosurgery. 2025. doi:10.3171/2025.4.jns243146

BibTeX
@article{Hu2025,
  author = {Hu, Wenxin and Zhao, Chuan and Zheng, Wenrong and Lin, Yi and Luo, Ning and Liu, Hongxing and Wang, Xingfu and Qi, Xueling and Wang, Xianlong and Li, Xiao-Nan and Lin, Zhixiong},
  title = {Use of integrated spatial transcriptomics and histopathological analysis in adamantinomatous craniopharyngiomas to identify stromal cells as a new cellular source of leukemia inhibitory factor},
  journal = {Journal of Neurosurgery},
  year = {2025},
  doi = {10.3171/2025.4.jns243146}
}
Kostenlos starten →